Clinical trials recruiting for Colon cancer
96
Recruiting trials
35
US states with sites
25
Countries
11%
Accept healthy volunteers
Phase breakdown
Drugs and treatments being studied
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| California | 10 |
| Maryland | 8 |
| Missouri | 8 |
| New York | 8 |
| Texas | 8 |
| Colorado | 7 |
| Florida | 7 |
| Massachusetts | 6 |
| Minnesota | 6 |
| Arizona | 5 |
| Tennessee | 5 |
| Illinois | 4 |
Top cities
Los Angeles, California 8New York, New York 6St Louis, Missouri 6Boston, Massachusetts 5Houston, Texas 5Nashville, Tennessee 5Bethesda, Maryland 4Denver, Colorado 4San Antonio, Texas 4Tampa, Florida 4
Self-screener
Recruiting trials
- A Clinico-biological Database in Cachexia in Patients With Colon Cancer
- A Manualized Post-Traumatic Growth Intervention for People With Cancer in Greece - IC-Growth
- A Phase I Clinical Study of Intratumoral Injection Oncolytic Vaccinia Virus GC001 in Patient With Advanced Solid Tumors
- A Randomized, Double-blind, Placebo-controlled, Parallel-group, Comparative, Phase III Study to Evaluate the Efficacy and Safety of Nuvastatic® 300mg Capsule in Reducing Cancer-Tumor in Patients With Metastatic Colorectal Cancer Receiving Standard Chemotherapy.
- A Study of Fruquintinib Plus FOLFIRI as Second-Line Treatment for Participants With Metastatic Colorectal Cancer (FRUITFUL)
- A Study of Neoadjuvant QL1706 in Participants With Untreated dMMR/MSI-H Resectable Colon Cancer
- A Study of PHN-012 in Patients With Advanced Solid Tumors
- A Study of SHY-ONC6, a Novel Proteasome Inhibitor, in Adults With Advanced or Metastatic Solid Tumors
- A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression
- A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
- A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Anti-tumor Activity of CBI-1214 T Cell Engager in Participants With Advanced or Metastatic MSS/MSI-L Colorectal Cancer
- A Trial of RSC-1255 for Treatment of Patients With Advanced Malignancies
- APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors
- Acute Colon Resection Versus Bridge to Colon Surgery With Stent or Stoma
- Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12V Variant of Mutated RAS in HLA-A*11:01 Patients
- Advanced Pelvic Surgical Oncology Database - Prospective Observational Study
- Analysis of Circulating Tumor Markers in Blood
- Artificial Intelligence System for Assessment of Tumor Risk and Diagnosis and Treatment
- Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative Disorders
- Avera Cancer Sequencing and Analytics Protocol (ASAP)
- Biological Tumor Infiltrating Lymphocytes Therapy With Immunotherapy for Colon and Rectum Cancer
- Biopsy After Radioembolization to Identify Changes in Tumor Cells From the Radiation
- Brodalumab in the Treatment of Immune-Related Adverse Events
- CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors
- CEA-Targeted CAR-T Therapy in CEA-Positive Advanced Solid Tumors
- COLON-MD: Colon Cancer Longitudinal Study
- Cancer Loyalty Card Study 2 (CLOCS-2)
- Chronic Loose Stools Following Right-sided Hemicolectomy for Colon Cancer and the Association With Bile Acid Malabsorption and Small Intestinal Bacterial Overgrowth Using a Novel Sampling Device
- Circulating Tumor DNA (ctDNA) for Early Treatment Response Assessment of Solid Tumors
- Circulating Tumor DNA Guided Adjuvant Chemotherapy for Colon Cancer
- Clinical Study of CEA Targeting Chimeric Antigen Receptor T Lymphocytes（CAR-T） for CEA Positive Advanced Malignant Solid Tumors
- Clinical Study of CEA-targeted CAR-T Therapy for CEA-positive Advanced/Metastatic Malignant Solid Tumors
- Clinical Study of Radical Right Hemicolectomy Versus Radical Right Hemicolectomy Combined with Indocyanine Green Fluorescence Imaging Lymphatic Tracer Dissection for the Treatment of Right Colon Cancer
- Clinical Trial on HIPEC With Mitomycin C in Colon Cancer Peritoneal Metastases (GECOP-MMC)
- Cold Snare Endoscopic Mucosal Resection (EMR) vs Cold EMR With Margin Snare Tip Soft Coagulation (STSC)
- Collection of Blood From Patients With Cancer
- Complete Mesocolic Excision in Comparison With Conventional Surgery for the Right Colon Cancer
- Contribution of Preserving the Superior Left Colic Artery to the Vascularization of the Descending Colon Prior to Colorectal Anastomosis During Left-Sided or Rectal Resections for Colorectal or Ovarian Cancer. (Revascularisation Colique)
- CtDNA in Adjuvant Chemotherapy of Stage III Colon Cancer (REVISE Trial)
- D2 vs D3 Lymph Node Dissection for Left Colon Cancer
- Development and Demonstration of Intelligent Assessment Based on Multi-modal Information Fusion for Tumor Risk and Diagnosis and Treatment
- Distance-Based Exercise to Preserve Function and Prevent Disability
- Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors
- Drug Sensitivity Detection of Micro Tumor (PTC) to Guide Postoperative Adjuvant Treatment Strategy of Colorectal Cancer
- EQUITY GI: A Prospective Study to Enhance Quality, Inclusivity, and Trial Participation in Black Patients With Gastrointestinal Cancer.
- EXCEL: Exercise for Cancer to Enhance Living Well
- EXoPERT EMERALD Clinical Study
- Effect of Perioperative Intravenous Infusion of Lidocaine on the Postoperative Course and the Immune Response in Patients Undergoing Surgery for Colon Cancer - the PILDI Study
- Effect of Perioperative Lidocaine or High-Dose Dexamethasone on Immune Response in Colon Cancer Surgery (PILDI Study)
- Encorafenib + Cetuximab Beyond Progression in Combination With FOLFIRI in Patients With BRAF V600E Mutated Metastatic Colorectal Cancer Progressing on Encorafenib + Cetuximab.
- Endoscopic Therapy Or Surgery for Early Colon Cancer
- Evaluation of Metastatic Disease and Oncological Treatment in Patients With Colon Cancer Using Zebra Fish Avatars
- Factors Affecting the Results of Treatment of Patients With Colorectal Cancer
- Follow-Up Study of Subjects Previously Enrolled in Poxviral Vector Gene Transfer Studies
- Genomic Services Research Program
- Immune Checkpoint Inhibitors for Organ Preservation in Non-metastatic dMMR/MSI-H Gastric or Colon Cancers
- Impact of Consumption of Ultra-processed Foods in Individuals at High Risk of Cancer
- Improving Care for Rural Patients With Solid Tumors
- Integrated Cancer Repository for Cancer Research
- Laparoscopic Versus Open Right Colectomy for Right Colon Cancer
- Leakage Rate of Ileo-COlic Sutured Anastomosis After Right Hemicolectomy
- Liquid Biopsy Evaluation and Repository Development at Princess Margaret
- MIMICC Study in Patients With Colorectal Cancer
- Mainstreaming Genetics: Evaluation of a Digital Application to Scale and Spread Oncologist-initiated Genetic Testing
- Mechanical Bowel Preparation in Laparoscopic Right Hemicolectomy With Intracorporeal Anastomosis
- Mesalamine for Colorectal Cancer Prevention Program in Lynch Syndrome
- Mesogastrium Metastasis in Colon Cancer
- Neoadjuvant Chemotherapy Plus Sequential Immune Checkpoint Inhibitor (ICI) Therapy in Locally Advanced Colon Cancer
- Neoadjuvant Chemotherapy for Obstructive Colon cancER First Treated by cOlostomy
- Node-Sparing Low-Dose Radiotherapy Concurrent With Chemotherapy and PD-1 Inhibitor in pMMR/MSS High-Risk Locally Advanced Colon Cancer: A Prospective, Single-Arm, Phase II Trial
- Oncologic Outcomes of Single-incision Versus Conventional Laparoscopic Surgery for Colorectal Cancer
- Optimised Post-discharge Care in Older Patients After Surgery for Colon Cancer (ERAS 3.0)
- Ovarian-Sparing Adaptive Radiotherapy in Young Adult Women
- PRE-ISPY Phase I/II Oncology Platform Program
- Personalising and Refining Neo-adjuvant Chemotherapy in Locally Advanced but Resecable Colon Cancer in the Elderly of 70 Years Old or More
- Phase II Trial of Lung Chemoemobolization
- Platform Study of Circulating Tumor DNA Directed Adjuvant Chemotherapy in Colon Cancer (KCSG CO22-12)
- Quality Of Life In Colorectal Cancer Survivors
- Radiotherapy + Systemic Therapy as Conversion Therapy for pMMR/MSS T4M0 Colon Cancer（Neo-Color）
- Resilience and Equity in Aging, Cancer, and Health (REACH)
- Safety and Tolerability of ²¹²Pb-DOTAM-GRPR1 in Adult Subjects With Recurrent or Metastatic GRPR-expressing Tumors
- Sequential TAS-OX Alternating With TAS-IRI Plus Bevacizumab for Late-Line Metastatic Colorectal Cancer
- Single Arm Study of Neoadjuvant Dostarlimab in Stage II and III Deficient Mismatch Repair Colon Cancers
- Stereotactic Body Radiotherapy in Patients With Rare Oligometastatic Cancers (OligoRARE)
- Stress-Reducing Intervention in Patients With Colorectal and Breast Cancer
- Study of Treatment With Intensified Omeprazole Treatment to Prevent High Output Stoma 1
- Study to Evaluate the Use of Surgical Gloves for the Prevention of Oxaliplatin-Induced Peripheral Neuropathy
- Sustainable Implementation of the EXCEL Exercise Oncology Program Across Canada
- Target-specific immunoPET Imaging of Digestive System Carcinoma
- The "SPARCOL" Study
- Transvaginal NOSES Versus Conventional Laparoscopic Surgery for Right Hemicolectomy
- Use of Ctdna in Patients With Gastrointestinal Tract Tumors
- Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes
- Washington University Participant Engagement and Cancer Genomic Sequencing Center (WU-PE-CGS)
- Xian-Lian-Jie-Du Optimization Decoction As an Adjuvant Treatment for Prevention of Recurrence of Colon Cancer
- ctDNA-guided Selection of Adjuvant Chemotherapy Regimens for Elderly Colon Cancer Patients After Surgery: A Single-center, Randomized, Controlled Study
Related conditions
Trials recruiting for Colon cancer often also study these conditions. Each links to its own recruiting-trial list.
Colorectal cancer 1359Lung cancer 2180Breast cancer 2239Pancreatic cancer 870Rectal cancer 152Gastric cancer 91Prostate cancer 1234Ovarian cancer 118Liver cancer 43Esophageal cancer 65
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Colon cancer trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.